Imugene strikes deals with Merck and Pfizer over manufacture
MELBOURNE: Paul Hopper-chaired biotech Imugene is taking further steps to validate its cancer vaccine HER-Vaxx,
MELBOURNE: Paul Hopper-chaired biotech Imugene is taking further steps to validate its cancer vaccine HER-Vaxx,
FEATURED
Transforming public health through social innovation
Thousands of elderly people evicted from care homes every year
Pilot study to improve staff interactions with residents with dementia
Psychological research informs how to maximise well-being during retirement
New affordable housing for seniors, veterans and disabled people created
Once-a-day Alzheimer’s pill reaches US approval milestone
INNOVATION
